{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:52:05Z","timestamp":1753876325870,"version":"3.41.2"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Heart failure concomitant with prolactinoma is extremely rare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We present the case of a 29-year-old man who had acute decompensated heart failure concomitant with visual loss in his right eye. Transthoracic echocardiography indicated severely decreased left ventricular (LV) function. A massive tumour on the sella turcica was detected by brain computed tomography. The findings of the laboratory tests showed hyperprolactinaemia with hypopituitarism, and the antigen test for coronavirus disease 2019 was positive as an incidental finding. Medication for heart failure and cabergoline therapy were started immediately. His LV function significantly improved, and he had no symptoms after a year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Prolactinoma in men, which can cause visual loss and hypopituitarism, is frequently substantial when diagnosed. The cardiac manifestation of prolactinoma is uncommon. It is believed that a major contributing component to the pathogenesis of peripartum cardiomyopathy is hyperprolactinaemia. Hyperprolactinaemia may cause endothelial damage and cardiomyocyte dysfunction, eventually resulting in LV dysfunction. The success of LV reverse remodelling may be significantly impacted by heart failure and hormone treatments. Heart failure and endocrine therapy should be administered concurrently to patients who have prolactinoma and congestive heart failure.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad487","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T15:23:57Z","timestamp":1696433037000},"source":"Crossref","is-referenced-by-count":0,"title":["An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction\u2014a case report"],"prefix":"10.1093","volume":"7","author":[{"given":"Wataru","family":"Saito","sequence":"first","affiliation":[{"name":"Cardiovascular Centre, Medical Research Institute Kitano Hospital , PIIF Tazuke-Kofukai, 2-4-20, Ogimachi, Kita-ku , Osaka 530-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Idouji","sequence":"additional","affiliation":[{"name":"Cardiovascular Centre, Medical Research Institute Kitano Hospital , PIIF Tazuke-Kofukai, 2-4-20, Ogimachi, Kita-ku , Osaka 530-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Shibue","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Medical Research Institute Kitano Hospital , PIIF Tazuke-Kofukai , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-1402","authenticated-orcid":false,"given":"Shinya","family":"Ito","sequence":"additional","affiliation":[{"name":"Cardiovascular Centre, Medical Research Institute Kitano Hospital , PIIF Tazuke-Kofukai, 2-4-20, Ogimachi, Kita-ku , Osaka 530-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"2023110910253330300_ytad487-B1","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMcp025334","article-title":"Prolactinoma","volume":"349","author":"Schlechte","year":"2003","journal-title":"N Engl J Med"},{"key":"2023110910253330300_ytad487-B2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","article-title":"Heart failure drug treatment: the fantastic four","volume":"42","author":"Bauersachs","year":"2021","journal-title":"Eur Heart J"},{"key":"2023110910253330300_ytad487-B3","first-page":"e25548","article-title":"Resolution of visual field defect in macroprolactinoma after treatment with cabergoline","volume":"14","author":"Shibue","year":"2022","journal-title":"Cureus"},{"key":"2023110910253330300_ytad487-B4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ejhf.1178","article-title":"Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"20","author":"Sliwa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2023110910253330300_ytad487-B5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker-Kleiner","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2023110910253330300_ytad487-B6","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"2023110910253330300_ytad487-B7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"2023110910253330300_ytad487-B8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/cen.13498","article-title":"Males with prolactinoma are at increased risk of incident cardiovascular disease","volume":"88","author":"Toulis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023110910253330300_ytad487-B9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"2023110910253330300_ytad487-B10","doi-asserted-by":"crossref","first-page":"e002135","DOI":"10.1161\/CIRCGEN.118.002135","article-title":"A-Band titin truncation in zebrafish causes dilated cardiomyopathy and hemodynamic stress intolerance","volume":"11","author":"Huttner","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2023110910253330300_ytad487-B11","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3390\/cells9112508","article-title":"Cardiovascular manifestations of COVID-19 infection","volume":"9","author":"Magadum","year":"2020","journal-title":"Cells"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad487\/51854654\/ytad487.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/11\/ytad487\/52958992\/ytad487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/11\/ytad487\/52958992\/ytad487.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T12:07:10Z","timestamp":1699531630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad487\/7288876"}},"subtitle":[],"editor":[{"given":"Valentina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Henrike Aenne Katrin","family":"Hillmann","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Deborah","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Athithan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad487","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,10,4]]},"article-number":"ytad487"}}